Patents by Inventor Adriana KATZ

Adriana KATZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11077128
    Abstract: Provided herein are alpha2-selective Na,K-ATPase inhibitors and prodrugs thereof, characterized by having a cyclic moiety attached to a digoxin or digitoxin derivative, as well as uses thereof in lowering intraocular pressure and in treating glaucoma and heart conditions.
    Type: Grant
    Filed: April 14, 2020
    Date of Patent: August 3, 2021
    Assignee: Yeda Research and Development Co. Ltd.
    Inventors: Steven J. D. Karlish, Adriana Katz, Daniel M. Tal, Arie Marcovich
  • Publication number: 20200297748
    Abstract: Provided herein are alpha2-selective Na,K-ATPase inhibitors and prodrugs thereof, characterized by having a cyclic moiety attached to a digoxin or digitoxin derivative, as well as uses thereof in lowering intraocular pressure and in treating glaucoma and heart conditions.
    Type: Application
    Filed: April 14, 2020
    Publication date: September 24, 2020
    Applicant: Yeda Research and Development Co. Ltd.
    Inventors: Steven J.D. KARLISH, Adriana KATZ, Daniel M. TAL, Arie MARCOVICH
  • Patent number: 10668094
    Abstract: Provided herein are alpha2-selective Na,K-ATPase inhibitors and prodrugs thereof, characterized by having a cyclic moiety attached to a digoxin or digitoxin derivative, as well as uses thereof in lowering intraocular pressure and in treating glaucoma and heart conditions.
    Type: Grant
    Filed: July 19, 2016
    Date of Patent: June 2, 2020
    Assignee: Yeda Research and Development Co. Ltd.
    Inventors: Steven J. D. Karlish, Adriana Katz, Daniel M. Tal, Arie Marcovich
  • Publication number: 20180207189
    Abstract: Provided herein are alpha2-selective Na,K-ATPase inhibitors and prodrugs thereof, characterized by having a cyclic moiety attached to a digoxin or digitoxin derivative, as well as uses thereof in lowering intraocular pressure and in treating glaucoma and heart conditions.
    Type: Application
    Filed: July 19, 2016
    Publication date: July 26, 2018
    Inventors: Steven J.D. KARLISH, Adriana KATZ, Daniel M. TAL, Arie MARCOVICH
  • Patent number: 9938316
    Abstract: The present invention relates to digoxin and digitoxin derivatives that are selective inhibitors of the ?2 isoform of Na,K-ATPase, and that reduce intra-ocular pressure. The invention further relates to uses of these derivatives for treating disorders associated with elevated intraocular pressure, such as glaucomas, and/or as cardiotonic agents.
    Type: Grant
    Filed: August 27, 2014
    Date of Patent: April 10, 2018
    Assignee: Yeda Research and Development Co. Ltd.
    Inventors: Steven J. D. Karlish, Adriana Katz, Daniel M. Tal, Arie Marcovich
  • Publication number: 20160244479
    Abstract: The present invention relates to digoxin and digitoxin derivatives that are selective inhibitors of the ?2 isoform of Na,K-ATPase, and that reduce intra-ocular pressure. The invention further relates to uses of these derivatives for treating disorders associated with elevated intraocular pressure, such as glaucomas, and/or as cardiotonic agents.
    Type: Application
    Filed: August 27, 2014
    Publication date: August 25, 2016
    Inventors: Steven J.D. KARLISH, Adriana KATZ, Daniel M. TAL